763 related articles for article (PubMed ID: 33912453)
1. Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients.
Chen RL; Sun LL; Cao Y; Chen HR; Zhou JX; Gu CY; Zhang Y; Wang SY; Hou W; Lin LZ
Front Oncol; 2021; 11():629394. PubMed ID: 33912453
[TBL] [Abstract][Full Text] [Related]
2. EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations.
Tang W; Li X; Xie X; Sun X; Liu J; Zhang J; Wang C; Yu J; Xie P
Lung Cancer; 2019 Oct; 136():6-14. PubMed ID: 31421260
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.
Zhao P; Zhen H; Zhao H; Zhao L; Cao B
BMC Cancer; 2022 Mar; 22(1):328. PubMed ID: 35346117
[TBL] [Abstract][Full Text] [Related]
4. Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials.
Zhang SL; Yi XF; Huang LT; Sun L; Ma JT; Han CB
BMC Cancer; 2023 Aug; 23(1):719. PubMed ID: 37528390
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer.
Cheng H; Li XJ; Wang XJ; Chen ZW; Wang RQ; Zhong HC; Wu TC; Cao QD
Lung Cancer; 2019 Nov; 137():7-13. PubMed ID: 31520922
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Adjuvant Setting for Patients with Resected Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer: A Meta-Analysis with 11 Trials.
Yin Q; Xun X; Yang G; Cui H; Liu H
Oncol Res Treat; 2021; 44(6):344-353. PubMed ID: 33951671
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis.
Raphael J; Vincent M; Boldt G; Shah PS; Rodrigues G; Blanchette P
Am J Clin Oncol; 2019 May; 42(5):440-445. PubMed ID: 30913091
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor inhibitors as adjuvant treatment for patients with resected non-small cell lung cancer harboring EGFR mutation: a meta-analysis of randomized controlled clinical trials.
Zhao N; Wu ZP; Yang J; Feng WN; Yang SL; Luo Y; Ye J; Wang F; Zhang XW; Xiao Y; Wu LL; Gu WQ
World J Surg Oncol; 2023 Feb; 21(1):45. PubMed ID: 36782320
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Adjuvant First-Generation TKIs versus Chemotherapy in Patients with Completely Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis.
Shen B; Wu D; Liu J; Yang Y
Cancer Invest; 2024 Jan; 42(1):63-74. PubMed ID: 38224061
[TBL] [Abstract][Full Text] [Related]
10. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
Wen M; Wang L; Wang X; Yang S; Sun Y; Xia J; Zhang Y; Zhang Z; Huang L; Jiang T
Oncol Res Treat; 2020; 43(12):686-693. PubMed ID: 33197924
[TBL] [Abstract][Full Text] [Related]
11. The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: A meta-analysis.
Lin C; Hu F; Chu H; Ren P; Ma S; Wang J; Bai J; Han X; Ma S
Thorac Cancer; 2021 Apr; 12(7):1084-1095. PubMed ID: 33660941
[TBL] [Abstract][Full Text] [Related]
12. Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations.
He Q; Liu J; Cai X; He M; Li C; Liang H; Cheng B; Xia X; Guo M; Liang P; Zhong R; Li F; Yu Z; Zhao Y; Ou L; Xiong S; Li J; Zhang J; He J; Liang W
Transl Lung Cancer Res; 2021 Nov; 10(11):4120-4129. PubMed ID: 35004243
[TBL] [Abstract][Full Text] [Related]
13. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer.
Cui R; Wei C; Li X; Jiang O
Medicine (Baltimore); 2022 Nov; 101(47):e31894. PubMed ID: 36451449
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of EGFR Tyrosine Kinase Inhibitors in the Adjuvant Treatment for Operable Non-small Cell Lung Cancer by a Meta-Analysis.
Huang Q; Li J; Sun Y; Wang R; Cheng X; Chen H
Chest; 2016 Jun; 149(6):1384-92. PubMed ID: 26836897
[TBL] [Abstract][Full Text] [Related]
16. Disease-free survival improved by use of adjuvant EGFR tyrosine kinase inhibitors in resectable non-small cell lung cancer: an updated meta-analysis.
Yuan Y; Huang Q; Gu C; Chen H
J Thorac Dis; 2017 Dec; 9(12):5314-5321. PubMed ID: 29312741
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer.
Zhai H; Zhong W; Yang X; Wu YL
Transl Lung Cancer Res; 2015 Feb; 4(1):82-93. PubMed ID: 25806348
[TBL] [Abstract][Full Text] [Related]
18. EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials.
Wu JX; He Q; Ye F; Zhou QX; Chen HJ; Sun L; Wu H
Onco Targets Ther; 2018; 11():6803-6810. PubMed ID: 30349313
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
Xie H; Wang H; Xu L; Li M; Peng Y; Cai X; Feng Z; Ren W; Peng Z
Clin Lung Cancer; 2018 Nov; 19(6):484-492. PubMed ID: 30369426
[TBL] [Abstract][Full Text] [Related]
20. The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
Melosky B; Cheema P; Juergens RA; Leighl NB; Liu G; Wheatley-Price P; Sacher A; Snow S; Tsao MS; McLeod D; Chu Q
Ther Adv Med Oncol; 2021; 13():17588359211056306. PubMed ID: 34804219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]